NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 141 filers reported holding NOVAVAX INC in Q1 2014. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $11,775,000 | +42.6% | 1,619,608 | +1.2% | 1.67% | +34.2% |
Q1 2016 | $8,256,000 | -38.5% | 1,600,000 | 0.0% | 1.24% | -22.5% |
Q4 2015 | $13,424,000 | +18.7% | 1,600,000 | 0.0% | 1.61% | -11.1% |
Q3 2015 | $11,312,000 | -36.5% | 1,600,000 | 0.0% | 1.81% | -23.8% |
Q2 2015 | $17,824,000 | +74.0% | 1,600,000 | +29.2% | 2.37% | +49.7% |
Q1 2015 | $10,241,000 | +15.1% | 1,238,300 | -17.4% | 1.58% | +15.4% |
Q4 2014 | $8,895,000 | +42.2% | 1,500,000 | 0.0% | 1.37% | +6.6% |
Q3 2014 | $6,255,000 | -9.7% | 1,500,000 | 0.0% | 1.29% | -29.9% |
Q2 2014 | $6,930,000 | +53.0% | 1,500,000 | +50.0% | 1.84% | +76.2% |
Q1 2014 | $4,530,000 | -11.5% | 1,000,000 | 0.0% | 1.04% | -29.9% |
Q4 2013 | $5,120,000 | – | 1,000,000 | – | 1.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |